| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.2M | +138.1% |
| Cost of Revenue | $15.0M | -6.4% |
| R&D Expense | $17.4M | -42.9% |
| SG&A Expense | $58.6M | +16.0% |
| Operating Income | -$38.4M | +80.1% |
| Pre-tax Income | -$57.9M | +70.5% |
| Income Tax | $10K | +0.0% |
| Net Income | -$57.9M | +70.5% |
| EPS (Basic) | -$2.64 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $738K | +225.1% |
| Accounts Receivable | $13.6M | +34.9% |
| Inventory | $5.4M | -6.0% |
| Current Assets | $20.6M | +3.9% |
| Total Assets | $132.7M | -7.8% |
| Current Liabilities | $53.7M | -20.2% |
| Total Liabilities | $123.8M | +20.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.4M | +83.5% |
| Capital Expenditures | $161K | -84.6% |
| Investing Cash Flow | $514K | +112.7% |
| Financing Cash Flow | $6.7M | -72.2% |
| Free Cash Flow | -$6.6M | +83.5% |
| +76.0% |
| EPS (Diluted) | -$2.64 | +76.0% |
| Stockholders' Equity |
| $8.8M |
| -78.4% |